| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | – | – | – | – | – |
| SG&A | $6.50M | $589.30K | $614.35K | $762.90K | $1.49M |
| Operating Income | -$127.96M | -$52.13M | -$40.27M | -$29.33M | -$41.29M |
| Interest Expense | – | – | – | – | – |
| Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 | – |
| Net Income | -$100.39M | -$14.48M | -$18.77M | -$28.71M | -$35.95M |
| EPS (basic) | -1.0800 | -0.2200 | -0.3000 | 0.4600 | 0.6600 |
| EPS (diluted) | -1.0800 | -0.2200 | -0.3000 | 0.4600 | 0.6600 |
| Shares (diluted) | $93.23M | $65.62M | $63.19M | $62.99M | $54.53M |